ST Elevation Myocardial Infarction Recruiting Phase 2 Trials for Alirocumab (DB09302)

IndicationStatusPhase
DBCOND0047428 (ST Elevation Myocardial Infarction)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03718286Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCIPrevention